Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
5.12
-0.03 (-0.58%)
At close: Apr 28, 2026, 4:00 PM EDT
5.17
+0.05 (0.98%)
After-hours: Apr 28, 2026, 6:42 PM EDT
Neuphoria Therapeutics Employees
As of June 30, 2025, Neuphoria Therapeutics had 8 total employees, including 7 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
8
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,873,342
Profits / Employee
-$707,989
Market Cap
27.60M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 8 | 0 | - |
| Jun 30, 2024 | 8 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Longeveron | 38 |
| Kyntra Bio | 34 |
| Jasper Therapeutics | 22 |
| Lisata Therapeutics | 21 |
| ABVC BioPharma | 19 |
| Tevogen Bio Holdings | 18 |
| NeuroSense Therapeutics | 17 |
| Outlook Therapeutics | 17 |
NEUP News
- 5 months ago - Leading Proxy Advisory Firm ISS Recommends that Shareholders Vote the WHITE Proxy Card FOR Both of Neuphoria's Director Nominees - GlobeNewsWire
- 5 months ago - Neuphoria Responds to Lynx1's Revised Indication of Interest at a Reduced Price and Premium - GlobeNewsWire
- 5 months ago - Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions - GlobeNewsWire
- 5 months ago - Neuphoria Therapeutics Inc. Sends Letter to Stockholders - GlobeNewsWire
- 6 months ago - Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value - GlobeNewsWire
- 6 months ago - Neuphoria Therapeutics Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Process - GlobeNewsWire
- 6 months ago - PACCAR Posts Downbeat Earnings, Joins Neuphoria Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
- 6 months ago - Neuphoria Therapeutics Provides Update on AFFIRM-1 Phase 3 Trial Evaluating BNC210 for the Acute Treatment of Social Anxiety Disorder - GlobeNewsWire